Medical News / From ASH Meeting 2019, Potential Sickle Cell Cure Targets BCL11A

There may soon be a cure for sickle cell disease. A team of investigators, led by Erica B. Esrick, MD, Children’s Hospital Boston, presented in a late-breaking abstract at the American Society of Hematology (ASH) 2019 a pilot and feasibility gene therapy study demonstrating the safety of an infusion of BCH-BB694-transduced autologous CD34+ cells in patients with severe sickle cell disease. Source: MDMag. By reading more or clicking on the link below, you are leaving this site and going to another site run by another organization.

read more

Beaumont Health’s 29th Annual Cardiovascular Conference in Beaver Creek, CO, this February built on its own ... read more
The 29th Annual Beaumont Health Cardiovascular Conference, held in Beaver Creek, CO, provided cardiology investigators and ... read more
Despite the progress made in the fight against cardiovascular disease in recent decades, stroke and mitigating ... read more
Using various sickle cell disease etiological conditions, investigators have identified several biomarkers associated with different cardiopulmonary, ... read more